Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Author: Benzinga Insights | March 07, 2024 09:06am

Gainers

  • NKGen Biotech (NASDAQ:NKGN) stock rose 18.0% to $2.16 during Thursday's pre-market session. The company's market cap stands at $47.2 million.
  • Nutex Health (NASDAQ:NUTX) stock increased by 15.32% to $0.12. The market value of their outstanding shares is at $91.9 million.
  • Avinger (NASDAQ:AVGR) stock moved upwards by 13.51% to $4.2. The company's market cap stands at $5.3 million.
  • Exicure (NASDAQ:XCUR) stock moved upwards by 12.66% to $0.74. The market value of their outstanding shares is at $6.4 million.
  • Ventyx Biosciences (NASDAQ:VTYX) shares rose 11.73% to $10.0. The company's market cap stands at $592.3 million.
  • Lucy Scientific Discovery (NASDAQ:LSDI) stock moved upwards by 11.05% to $1.91. The market value of their outstanding shares is at $3.3 million.

Losers

  • Avid Bioservices (NASDAQ:CDMO) stock declined by 37.4% to $5.5 during Thursday's pre-market session. The company's market cap stands at $347.8 million.
  • Emergent BioSolutions (NYSE:EBS) stock fell 16.57% to $2.72. The market value of their outstanding shares is at $141.1 million. As per the news, the Q4 earnings report came out yesterday.
  • Nexalin Technology (NASDAQ:NXL) stock decreased by 13.47% to $0.45. The market value of their outstanding shares is at $3.2 million.
  • CASI Pharmaceuticals (NASDAQ:CASI) shares declined by 10.53% to $5.27. The market value of their outstanding shares is at $70.2 million.
  • Immuron (NASDAQ:IMRN) shares fell 9.42% to $3.08. The company's market cap stands at $17.5 million.
  • Trxade Health (NASDAQ:MEDS) shares declined by 8.81% to $15.74. The company's market cap stands at $18.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AVGR CASI CDMO EBS IMRN LSDI MEDS NKGN NUTX NXL VTYX XCUR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist